Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Rodriguez-Ubreva

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2011
SHP-1 in cell-cycle regulationPilar López-Ruiz, Javier Rodriguez-Ubreva, Ariel Ernesto Cariaga, et al.
Molecular and Cellular Biology|January 15, 2014
C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophagesJavier Rodriguez-Ubreva, Laura Ciudad, Chris van Oevelen, et al.
Cellular Signalling|April 10, 2013
Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cellsAriel E Cariaga-Martinez, Pilar López-Ruiz, M Paz Nombela-Blanco, et al.
Cell Stem Cell|November 10, 2009
A robust and highly efficient immune cell reprogramming systemLars H Bussmann, Alexis Schubert, Thien Phong Vu Manh, et al.
Nature|February 14, 2014
Geriatric muscle stem cells switch reversible quiescence into senescencePedro Sousa-Victor, Susana Gutarra, Laura García-Prat, et al.
Molecular Cancer Research : MCR|July 9, 2011
Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cellsBiola M Javierre, Javier Rodriguez-Ubreva, Fatima Al-Shahrour, et al.
Genome Research|December 24, 2009
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosusBiola M Javierre, Agustin F Fernandez, Julia Richter, et al.
Haematologica|February 23, 2023
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiencyOskar Marin-Bejar, Damia Romero-Moya, Javier Rodriguez-Ubreva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2011
SHP-1 in cell-cycle regulationPilar López-Ruiz, Javier Rodriguez-Ubreva, Ariel Ernesto Cariaga, et al.
Molecular and Cellular Biology|January 15, 2014
C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophagesJavier Rodriguez-Ubreva, Laura Ciudad, Chris van Oevelen, et al.
Cellular Signalling|April 10, 2013
Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cellsAriel E Cariaga-Martinez, Pilar López-Ruiz, M Paz Nombela-Blanco, et al.
Cell Stem Cell|November 10, 2009
A robust and highly efficient immune cell reprogramming systemLars H Bussmann, Alexis Schubert, Thien Phong Vu Manh, et al.
Nature|February 14, 2014
Geriatric muscle stem cells switch reversible quiescence into senescencePedro Sousa-Victor, Susana Gutarra, Laura García-Prat, et al.
Molecular Cancer Research : MCR|July 9, 2011
Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cellsBiola M Javierre, Javier Rodriguez-Ubreva, Fatima Al-Shahrour, et al.
Genome Research|December 24, 2009
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosusBiola M Javierre, Agustin F Fernandez, Julia Richter, et al.
Haematologica|February 23, 2023
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiencyOskar Marin-Bejar, Damia Romero-Moya, Javier Rodriguez-Ubreva, et al.
Pageof 1